Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02887976
Title Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201
Recruitment Completed
Gender male
Phase Phase III
Variant Requirements No
Sponsors GU Research Network, LLC
Indications

prostate cancer

Therapies

Abiraterone + Methylprednisolone

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.